Marsha E. Reichman

10.3k citations

65 papers · 7.7k indexed · 4 hit papers · h-index 36

Internal Medicine top 0.5%
Hepatology top 1%
Oncology top 1%
- Global Cancer Incidence and Screening 6
- Cancer Risks and Factors 5
- Colorectal Cancer Screening and Detection 5
Otorhinolaryngology top 1%
Cardiology and Cardiovascular Medicine top 2%
- Atrial Fibrillation Management and Outcomes 5
Molecular Biology
- RNA and protein synthesis mechanisms 5
Genetics
- Estrogen and related hormone effects 5
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
Public Health, Environmental and Occupational Health
- Pregnancy and Medication Impact 4

Co-authors: Sean F. Altekruse Katherine A. McGlynn Brenda K. Edwards Nadia Howlader Matthew J. Hayat Mary Southworth Lynn A. G. Ries Benjamin F. Hankey
Cited by: Internal Medicine Hepatology Oncology
Journals: New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (2 papers)JAMA (1 paper)
Partner nations: United States Canada Australia

In The Last Decade

Marsha E. Reichman

65 papers receiving 7.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2014 Circulation
2009 Journal of Clinical Oncology
2008 Cancer Causes & Control
2007 The Oncologist

Peers

Countries citing papers authored by Marsha E. Reichman

Since Specialization

Citations

This map shows the geographic impact of Marsha E. Reichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marsha E. Reichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marsha E. Reichman more than expected).

Fields of papers citing papers by Marsha E. Reichman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marsha E. Reichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marsha E. Reichman. The network helps show where Marsha E. Reichman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marsha E. Reichman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marsha E. Reichman Line = papers co-authored together Marsha E. Reichman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation The American Journal of Medicine ·David J. Graham,Elande Baro,Rongmei Zhang,Jiemin Liao,Michael Wernecke,Marsha E. Reichman,Mao Hu,Onyekachukwu A. Illoh,Yuqin Wei,Margie R. Goulding,Yoganand Chillarige,Mary Southworth,Thomas MaCurdy,Jeffrey A. Kelman	2019	98
2	Use of Antidiabetic drugs during pregnancy among U.S. women with Livebirth deliveries in the Mini-Sentinel system BMC Pregnancy and Childbirth ·Katrina Mott,Marsha E. Reichman,Sengwee Toh,Caren Kieswetter,Katherine Haffenreffer,Susan E. Andrade	2019	5
3	Antiemetic use among pregnant women in the United States: the escalating use of ondansetron Pharmacoepidemiology and Drug Safety ·Lockwood G. Taylor,Steven T. Bird,Leyla Şahin,Melissa S. Tassinari,Patty Greene,Marsha E. Reichman,Susan E. Andrade,Katherine Haffenreffer,Sengwee Toh	2017	47
4	A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data SHILAP Revista de lepidopterología ·Jennifer C. Nelson,Robert Wellman,Onchee Yu,Andrea J. Cook,Judith C. Maro,Rita Ouellet‐Hellstrom,Denise M. Boudreau,James S. Floyd,Susan R. Heckbert,Simone Pinheiro,Marsha E. Reichman,Azadeh Shoaibi	2016	7
5	Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration’s Mini-Sentinel program Archives of Women s Mental Health ·Susan E. Andrade,Marsha E. Reichman,Katrina Mott,Marilyn Pitts,Caren Kieswetter,Miriam Dinatale,Marc B. Stone,Jennifer Popovic,Katherine Haffenreffer,Sengwee Toh	2016	39
6	Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program Maternal and Child Health Journal ·Susan E. Andrade,Sengwee Toh,Monika Houstoun,Katrina Mott,Marilyn Pitts,Caren Kieswetter,Carrie Ceresa,Katherine Haffenreffer,Marsha E. Reichman	2015	31
7	Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillationbreakdown → Circulation ·David J. Graham,Marsha E. Reichman,Michael Wernecke,Rongmei Zhang,Mary Southworth,Mark Levenson,Ting-Chang Sheu,Katrina Mott,Margie R. Goulding,Monika Houstoun,Thomas MaCurdy,Chris Worrall,Jeffrey A. Kelman	2014	498
8	Improved Estimates of Cancer-Specific Survival Rates From Population-Based Data JNCI Journal of the National Cancer Institute ·Nadia Howlader,Lynn A. G. Ries,Angela B. Mariotto,Marsha E. Reichman,Jennifer Ruhl,Kathleen A. Cronin	2010	358
9	Implicit Value Judgments in the Measurement of Health Inequalities Milbank Quarterly ·Sam Harper,Nicholas B. King,Stephen C. Meersman,Marsha E. Reichman,Nancy Breen,John Lynch	2010	217
10	Estimating breast cancer‐specific and other‐cause mortality in clinical trial and population‐based cancer registry cohorts Cancer ·James J. Dignam,Lan Huang,Lynn A. G. Ries,Marsha E. Reichman,Angela B. Mariotto,Eric J. Feuer	2009	42
11	Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program Breast Cancer Research and Treatment ·W. French Anderson,Sheng Luo,Nilanjan Chatterjee,Philip S. Rosenberg,Rayna K. Matsuno,Marc T. Goodman,Brenda Y. Hernandez,Marsha E. Reichman,Marisa Dolled‐Filhart,Ruth O’Regan,Montserrat García‐Closas,Charles M. Perou,Ismail Jatoi,Richard W. Cartun,Mark E. Sherman	2008	34
12	Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods Cancer ·Meg Watson,Mona Saraiya,Faruque Ahmed,Cheryll J. Cardinez,Marsha E. Reichman,Hannah K. Weir,Thomas B. Richards	2008	131
13	Tissues from population-based cancer registries: a novel approach to increasing research potential Human Pathology ·Marc T. Goodman,Brenda Y. Hernandez,Stephen M. Hewitt,Charles F. Lynch,Timothy R. Coté,Henry F. Frierson,Christopher A. Moskaluk,Jeffrey Killeen,Wendy Cozen,Charles R. Key,Limin X. Clegg,Marsha E. Reichman,Benjamin F. Hankey,Brenda K. Edwards	2005	35
14	Alcohol and Prostate Cancer in the NHANES I Epidemiologic Follow-Up Study Annals of Epidemiology ·Rosalind A. Breslow,Louise Wideroff,Barry I. Graubard,Diane Erwin,Marsha E. Reichman,Regina G. Ziegler,Rachel Ballard‐Barbash	1999	42
15	Possible mechanisms mediating an association between physical activity and breast cancer Cancer ·Laurie Hoffman-Goetz,Dan Apter,Wendy Demark‐Wahnefried,Michael I. Goran,Anne McTiernan,Marsha E. Reichman	1998	101
16	The relation of body size to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States) Cancer Causes & Control ·Joanne F. Dorgan,Marsha E. Reichman,Joseph T. Judd,Charles Brown,Christopher Longcope,Arthur Schatzkin,Demetrius Albanes,William S. Campbell,Charlene Franz,Lisa Kahle,Philip R. Taylor	1995	43
17	Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. PubMed ·Joanne F. Dorgan,Marsha E. Reichman,J T Judd,Carolyn A. Brown,Christopher Longcope,Arthur Schatzkin,W S Campbell,C Franz,Lisa Kahle,Philip R. Taylor	1995	89
18	The Activity of Parafusin Is Distinct from That of Phosphoglucomutase in the Unicellular Eukaryote Paramecium Biochemical and Biophysical Research Communications ·Anders Poul Andersen,Elżbieta Wyroba,Marsha E. Reichman,H. Zhao,Birgit H. Satir	1994	18
19	Effects of Alcohol Consumption on Plasma and Urinary Hormone Concentrations in Premenopausal Women JNCI Journal of the National Cancer Institute ·Marsha E. Reichman,J T Judd,Christopher Longcope,Arthur Schatzkin,Beverly A. Clevidence,Padmanabhan P. Nair,W S Campbell,Philip R. Taylor	1993	286
20	EPIDEMIOLOGIC ISSUES IN THE DESIGN AND USE OF BIOLOGIC SPECIMEN BANKS Epidemiologic Reviews ·Deborah M. Winn,Marsha E. Reichman,Elaine W. Gunter	1990	18

About Marsha E. Reichman

Marsha E. Reichman is a scholar working on Family Practice, Toxicology and Otorhinolaryngology, having authored 65 papers that have together received 7.7k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (6 papers), RNA and protein synthesis mechanisms (5 papers), Estrogen and related hormone effects (5 papers), Cancer Risks and Factors (5 papers), Atrial Fibrillation Management and Outcomes (5 papers), Colorectal Cancer Screening and Detection (5 papers), Pregnancy and Medication Impact (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). The work is most often cited by research in Internal Medicine (552 citations), Hepatology (841 citations) and Oncology (2.1k citations). Marsha E. Reichman has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Sean F. Altekruse, Katherine A. McGlynn, Brenda K. Edwards, Nadia Howlader, Matthew J. Hayat, Mary Southworth, Lynn A. G. Ries, Benjamin F. Hankey, Ellis F. Unger and David J. Graham. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact